Navigation Links
Innovative Uses of Technology to Improve Health for Poor and Vulnerable People to be Explored at Rockefeller Foundation Conference
Date:6/2/2008

Global Consensus and New Partnerships Sought to Improve Health Systems in

Developing Countries

NEW YORK, June 2 /PRNewswire/ -- Accelerating innovative applications of emerging digital technologies to improve the health of poor and vulnerable people around the world -- a field known as eHealth -- will be the main topic of a major international conference hosted by the Rockefeller Foundation. The conference, Making the eHealth Connection: Global Partnerships, Local Solutions, will take place from July 13 to August 8, 2008.

Working with twelve leading organizations from the fields of global health, international development, and information and communications technology (ICT), the Rockefeller Foundation and its partners will bring together luminaries from industry, government, and civil society as well as donors and researchers at its Bellagio Center in Italy. The action-oriented agenda will focus on how deploying eHealth and ICT in health systems can improve the access, efficiency and quality of health services. Importantly, the conference focus is on the Global South-developing countries-where health infrastructure and capacity challenges loom large and eHealth technology, a lynchpin in modern health care systems, is at a tipping point. The conference will set the stage for long-term sustainable collaboration in the eHealth field.

"The emerging field of eHealth seeks to harness the power of ICT to strengthen health systems and help billions of people access affordable health care," said Judith Rodin, President of the Rockefeller Foundation. "We believe that Making the eHealth Connection, this summer's conference at the Rockefeller Foundation Bellagio Center, can dramatically advance efforts to meet this critical challenge by building the necessary coalitions and resources."

Participants at the month-long Making the eHealth Connection conference will engage in intense high-level discussions that aim to adv
'/>"/>

SOURCE The Rockefeller Foundation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Riverside Partners Teams with Management to Acquire Innovative Product Achievements
2. TriWest Receives National Awards for Innovative Video Communications to Military Community
3. Medsn to Become Indegene Pharmaceutical Solutions, Inc.: Change Signifies the Success of Its Innovative Global Services Model
4. Innovative antennae may signal a new wave in health care provision
5. Beautiful Teeth Not Just for the Dentists Office Anymore / SpaBrite Teeth Whitening System(TM) Introduces Innovative, New Teeth Whitening Experience To Spas
6. Two Michigan Orthopedic Surgeons Pioneer Innovative ACL Surgery with New Benefits for Athletes, Weekend Warriors
7. In blood vessel stents, innovative materials allow better control, delivery of gene therapy
8. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
9. Bank of America Launches Innovative Approach to Managing Health Care
10. CardWorks Named Servicer of Choice for Innovative Credit Card for Healthcare Services
11. London Luxury LLC Announces Exclusive Partnership with Cupron, Inc., to Develop Innovative Copper-Infused Bed and Bath Products
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Mesa Labs Increases Quarterly Dividend 61255 1Neogen to Ring NASDAQs Closing Bell 14815 1Neogen to Ring NASDAQs Closing Bell 14815 2Corgenix Reports Financial Results for First Quarter of Fiscal 2010 6217 1Corgenix Reports Financial Results for First Quarter of Fiscal 2010 6217 2Corgenix Reports Financial Results for First Quarter of Fiscal 2010 6217 3